G2G CONSULTING

Lobbying for SHEPHERD THERAPEUTICS · rare cancer R&D

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · posted Oct 14, 2025

Lobbying activity 4

Budget/Appropriations

regarding funding and awareness of rare cancers

Health Issues

regarding funding and awareness of rare cancers

Defense

regarding funding and awareness of rare cancers

Veterans

regarding funding and awareness of rare cancers

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.